NCT03165097 - Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

November 15, 2018

Study Completion Date

December 28, 2018

Conditions

Healthy Subjects

Interventions

DRUG

ACT-709478

Hard gelatine capsules for oral administration

DRUG

Placebo

Placebo capsules matching ACT-709478 capsules

DRUG

Midazolam

Midazolam oral solution (2 mg/mL) applied with a syringe

DRUG

ACT-709478 combined with midazolam

Hard gelatine capsules for oral administration (ACT-709478) to be taken first followed by Midazolam oral solution (2 mg/mL) applied with a syringe

Trial Locations (1)

Parexel, Berlin